5,438
Views
2
CrossRef citations to date
0
Altmetric
Editorial

The long and short of vegetations in infective endocarditis

Pages 529-533 | Published online: 10 Jan 2014

References

  • Tleyjeh IM, Steckelberg JM, Murad HS et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA293(24), 3022–3028 (2005).
  • Cabell CH, Jollis JG, Peterson GE et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch. Intern. Med.162(1), 90–94 (2002).
  • Fowler VG Jr, Miro JM, Hoen B et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA293(24), 3012–3021 (2005).
  • Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA289(15), 1933–1940 (2003).
  • Mourvillier B, Trouillet JL, Timsit JF et al. Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients. Intensive Care Med.30(11), 2046–2052 (2004).
  • Li JS, Sexton DJ, Mick N et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin. Infect. Dis.30(4), 633–638 (2000).
  • Mandell GL, Douglas RG, Bennett JE, Dolin R. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. (6th Edition). Elsevier/Churchill Livingstone, PA, USA 975–1022 (2005).
  • Baddour LM, Wilson WR, Bayer AS et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation111(23), e394–e434 (2005).
  • Miro JM, Anguera I, Cabell CH et al. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin. Infect. Dis.41(4), 507–514 (2005).
  • Thuny F, Di Salvo G, Belliard O et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation112(1), 69–75 (2005).
  • Di Salvo G, Habib G, Pergola V et al. Echocardiography predicts embolic events in infective endocarditis. J. Am. Coll. Cardiol.37(4), 1069–1076 (2001).
  • Mugge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J. Am. Coll. Cardiol.14(3), 631–638 (1989).
  • Rohmann S, Erbel R, Gorge G et al. Clinical relevance of vegetation localization by transoesophageal echocardiography in infective endocarditis. Eur. Heart J.13(4), 446–452 (1992).
  • Vilacosta I, Graupner C, San Roman JA et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J. Am. Coll. Cardiol.39(9), 1489–1495 (2002).
  • Steckelberg JM, Murphy JG, Ballard D et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann. Intern. Med.114(8), 635–640 (1991).
  • Cabell CH, Pond KK, Peterson GE et al. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am. Heart J.142(1), 75–80 (2001).
  • Rohmann S, Erbel R, Darius H et al. Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size. J. Am. Soc. Echocardiogr.4(5), 465–474 (1991).
  • Rohmann S, Erhel R, Darius H, Makowski T, Meyer J. Effect of antibiotic treatment on vegetation size and complication rate in infective endocarditis. Clin. Cardiol.20(2), 132–140 (1997).
  • Vuille C, Nidorf M, Weyman AE, Picard MH. Natural history of vegetations during successful medical treatment of endocarditis. Am. Heart J.128(6 Pt 1), 1200–1209 (1994).
  • Aksoy O, Sexton DJ, Wang A et al. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin. Infect. Dis.44(3), 364–372 (2007).
  • Cabell CH, Abrutyn E, Fowler VG Jr et al. Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database. Am. Heart J.150(5), 1092–1098 (2005).
  • Tleyjeh IM, Ghomrawi HM, Steckelberg JM et al. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation115(13), 1721–1728 (2007).
  • Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA290(24), 3207–3214 (2003).
  • Wang A, Pappas P, Anstrom KJ et al. The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort. Am. Heart J.150(5), 1086–1091 (2005).
  • Olaison L, Pettersson G. Current best practices and guidelines indications for surgical intervention in infective endocarditis. Infect. Dis. Clin. North Am.16(2), 453–475, xi (2002).
  • Ruttmann E, Willeit J, Ulmer H et al. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke37(8), 2094–2099 (2006).
  • Ting W, Silverman N, Levitsky S. Valve replacement in patients with endocarditis and cerebral septic emboli. Ann. Thorac. Surg.51(1), 18–21 (1991).
  • Scheld WM, Valone JA, Sande MA. Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J. Clin. Invest.61(5), 1394–1404 (1978).
  • Shapiro S, Kupferwasser LI. Echocardiography predicts embolic events in infective endocarditis. J. Am. Coll. Cardiol.37(4), 1077–1079 (2001).
  • Nicolau DP, Freeman CD, Nightingale CH et al. Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis. Infect. Immun.61(4), 1593–1595 (1993).
  • Nicolau DP, Marangos MN, Nightingale CH, Quintiliani R. Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis. Antimicrob. Agents Chemother.39(8), 1748–1751 (1995).
  • Chan KL, Dumesnil JG, Cujec B et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J. Am. Coll. Cardiol.42(5), 775–780 (2003).
  • Anavekar NS, Tleyjeh IM, Anavekar NS et al. Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin. Infect. Dis.44(9), 1180–1186 (2007).
  • Dhawan VK, Bayer AS, Yeaman MR. In vitro resistance to thrombin-induced platelet microbicidal protein is associated with enhanced progression and hematogenous dissemination in experimental Staphylococcus aureus infective endocarditis. Infect. Immun.66(7), 3476–3479 (1998).
  • Fowler VG Jr, McIntyre LM, Yeaman MR et al. In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. J. Infect. Dis.182(4), 1251–1254 (2000).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.